TPOXX FDA approval date

The FDA approved TPOXX (tecovirimat) on 13 Jul 2018.

FDA approval date
13 Jul 2018

Drug identity checked against registry records

Also recorded as tecovirimat

Included trials

TrialSponsorPhaseStatusPrimary completion
Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 DaysNCT04971109SIGA TechnologiesPhase 3Completed2023-05-12Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2018-07-13DayTPOXXFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208627", "applicant_as_listed_by_fda": "SIGA TECHNOLOGIES", "brand_names": ["TPOXX"], "active_ingredients": ["TECOVIRIMAT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20180713", "matched_on": "drug name equals FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026